Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis
β Scribed by Amelia Fernandez-Martin; Elena Gonzalez-Rey; Alejo Chorny; Doina Ganea; Mario Delgado
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 342 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Multiple sclerosis (MS) is a debilitating neurological disease characterized by a progressive loss of motor and sensory function, eventually leading to paralysis and death. The primary cause of neurological impairment is demyelination of the central nervous system (CNS) caused by an inf
## Abstract Experimental autoimmune encephalomyelitis (EAE) is a CD4^+^ T cell disease of the central nervous system (CNS) characterized by mononuclear cell infiltration, demyelination, and paralysis. Recent studies describing the relationship of chemokine expression with development of clinical di
## Abstract A key question in the field of autoimmunity concerns the fact that experimental disease is generally induced more easily with closely related, but not completely identical, tissueβrestricted antigens. Here, the possibility that naturally occurring regulatory T cells (Tregs) for selfβant
T cell co-stimulation through the CD28 receptor on T cells is critical to the induction of experimental autoimmune encephalomyelitis (EAE). In this study, expression of the co-stimulatory ligands B7-1 (CD80) and B7-2 (CD86), as well as the receptors CD28 and CTLA-4, were quantitated in central nervo